|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/53 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2805728 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14164624.0 |
| Date of filing the European patent application | 2004-12-23 | |
| (97) | Date of publication of the European application | 2014-11-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-05 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (30) | Number | Date | Country code |
| 532130 P | 2003-12-23 | US |
| (72) |
Fung, Sek Chung Michael, US
Moyle, Matthew, US
Lu, Mason, US
Yan, Changning, US
Singh, Sanjaya, US
Huang, Dan, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Nauji anti-IL 13 antikūnai ir jų naudojimai |
| Novel anti-IL 13 antibodies and uses thereof |
| Payment date | Validity (years) | Amount | |
| 2023-11-22 | 347.00 EUR |